James Oliviero
Chief Executive Officer at CHECKPOINT THERAPEUTICS, INC.
Net worth: 4 M $ as of 31/05/2024
James Oliviero active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Director/Board Member | 15/10/2018 | - |
| Chief Executive Officer | 13/10/2015 | - | |
| President | 13/10/2015 | - | |
| NUVECTIS PHARMA, INC. | Director/Board Member | 01/07/2021 | - |
| Independent Dir/Board Member | 01/07/2021 | - |
Career history of James Oliviero
Former positions of James Oliviero
| Companies | Position | Start | End |
|---|---|---|---|
| KERYX BIOPHARMACEUTICALS | Comptroller/Controller/Auditor | 01/05/2003 | 17/04/2015 |
| Director of Finance/CFO | 01/04/2009 | 01/09/2015 | |
| Corporate Secretary | 01/05/2003 | 17/04/2015 | |
| Treasurer | 01/05/2003 | 01/09/2015 | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Director of Finance/CFO | 01/08/1999 | 01/05/2003 |
Training of James Oliviero
| Goizueta Business School-Emory | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Director of Finance/CFO | 2 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Health Technology |
| NUVECTIS PHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Health Technology |
- Stock Market
- Insiders
- James Oliviero
- Experience
